A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis
Brief description of study
The primary objective of this study is to observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-Sponsored filgotinib treatment study in UC. The secondary objective of this study is to evaluate the effect of filgotinib on partial Mayo Clinic Score and to evaluate health-related quality of life. This is a long-term extension study. Some people in this study will receive open-label drug and some will receive double-blind drug. Open-label means you and your study doctor will know what study drug you will be taking. Double-blind means you and your study doctor will not know what study drug you will be taking.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
